FIFTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 23rd, 2021 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
THIS FIFTH AMENDMENT TO CREDIT AGREEMENT (this “Agreement”), dated as of February 19, 2021 (the “Fifth Amendment Effective Date”), is entered into among RECRO PHARMA, INC., a Pennsylvania corporation (the “Borrower”), the Guarantors party hereto, the Lenders party hereto and ATHYRIUM OPPORTUNITIES III ACQUISITION LP, as Administrative Agent (the “Administrative Agent”). All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).
STOCK ISSUANCE AGREEMENTStock Issuance Agreement • February 23rd, 2021 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
This STOCK ISSUANCE AGREEMENT (this “Agreement”) is made as of this 19th day of February, 2021 (the “Effective Date”), by and between Recro Pharma, Inc., a Pennsylvania corporation, having its principal place of business at 490 Lapp Road, Malvern, Pennsylvania 19355 (the “Company”), and Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP, each a limited partnership organized under the laws of Delaware, having its principal place of business at 505 Fifth Avenue, Floor 18, New York, New York 10017 (collectively “Athyrium” and each an “Athyrium Entity”).
